Micro Emerging Active

UBS alza l'obiettivo di prezzo di Amgen

New narrative with limited coverage — still forming.

Punteggio
0,4
Velocità
▲ 0,0
Articoli
2
Fonti
1

Sentiment Timeline

Event Timeline

Apr 24, 2026
Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead … Neutral
Apr 19, 2026
UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 Neutral

Articoli Correlati

Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead of Earnings

Yahoo Finance · Apr 24, 2026
Mixed

Cronologia

Ultimo aggiornamentoApr 19, 2026